Biostar Pharmaceuticals's total assets for Q were $41.43M, an increase of 1.59% from the previous quarter. BSPM total liabilities were $5.28M for the fiscal quarter, a -0.22% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.